Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
INSM > SEC Filings for INSM > Form 8-K on 7-Nov-2012All Recent SEC Filings

Show all filings for INSMED INC

Form 8-K for INSMED INC


Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Sta

Item 2.02. Results of Operations and Financial Condition.

On November 7, 2012, Insmed Incorporated issued a press release regarding its financial results for the nine months ended June 30, 2012. A copy of the press release is attached hereto as Exhibit 99.1.

The information contained herein, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01. Regulation FD Disclosure.

On November 7, 2012, William Lewis, Chief Executive Officer of the Company announced his intention to implement a stock purchase plan (the "10b5-1 Plan") before December 15, 2012. Rule 10b5-1 allows corporate officers, directors and other employees to adopt written, prearranged stock trading plans when not in possession of material non-public information.

Under Mr. Lewis' 10b5-1 Plan, a broker would be authorized to purchase shares of the Company's common stock up to an aggregate of $100,000 on or before December 31, 2012 and up to $75,000 in each calendar quarter in 2013, subject in each case to the terms and conditions of the 10b5-1 Plan, including purchase price thresholds. The timing within each calendar quarter and execution of all purchases would be made at the sole discretion of the broker. The 10b5-1 Plan is expected to terminate, subject to certain conditions, no later than December 31, 2013. However, the 10b5-1 Plan will terminate earlier upon the purchase of an aggregate of $400,000 of shares pursuant to the 10b5-1 Plan.

The Company expects that all purchases under the 10b5-1 Plan will be reported by Mr. Lewis through Form 4 filings with the Securities and Exchange Commission. Except as may be required by law, the Company does not undertake to report on specific Rule 10b5-1 trading plans of the Company's officers or any transactions under such plans, nor to report on the approval, implementation, modification or termination, or the specific terms and conditions of, Mr. Lewis' 10b5-1 Plan or the plan of any other individual.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description

99.1 Press Release issued by Insmed Incorporated on November 7, 2012

  Add INSM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for INSM - All Recent SEC Filings
Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.